Isoprenoid metabolism as a therapeutic target in gram-negative pathogens

Current Topics in Medicinal Chemistry

Volumn 10, Issue 18, 2010, Pages 1858-1871

  Wiemer, Andrew J ^a   Hsiao, Chia Hung Christine ^a   Wiemer, David F ^b  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b E11 SSH   (United States)

Author keywords

Bisphosphonate; Escherichia coli; Farnesyl diphosphate; Farnesyl pyrophosphate; Geranylgeranyl diphosphate synthase; Gram negative; Isoprene; MEP pathway; Mevalonate pathway; Terpene

Indexed keywords

ANTIBIOTIC AGENT; FARNESYL DIPHOSPHATE; FOSMIDOMYCIN; ISOPRENE; ISOPRENOID; MENAQUINONE; PEPTIDOGLYCAN; PLASTOQUINONE; PROTEIN FARNESYLTRANSFERASE; QUINONE DERIVATIVE; RHODOQUINONE; SYNTHETASE; TRANSFERASE; UBIQUINONE; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL CELL WALL; BACTERIAL GROWTH; DRUG METABOLISM; DRUG STRUCTURE; ELECTRON TRANSPORT; ENTEROBACTERIACEAE; GRAM NEGATIVE BACTERIUM; HUMAN; MULTIDRUG RESISTANCE; NONHUMAN;

EID: 78649969466     PISSN: 15680266     EISSN: None     Source Type: Journal    
DOI: 10.2174/156802610793176602     Document Type: Article

References (117)

1. Nataro, J. P. and Kaper, J. B. Diarrheagenic Escherichia coli. Clin. Microbiol. Rev., 1998, 11, 142-201.
2. Hanning, I. B.; Nutt, J. D.; Ricke, S. C. Salmonellosis outbreaks in the United States due to fresh produce: sources and potential intervention measures. Foodborne Pathog. Dis., 2009, 6, 635-648.
3. Basnyat, B.; Maskey, A. P.; Zimmerman, M. D.; Murdoch, D. R. Enteric (typhoid) fever in travelers. Clin. Infect. Dis., 2005, 41, 1467-1472.
4. Niyogi, S. K. Shigellosis. J. Microbiol., 2005, 43, 133-143.
5. Meskhidze, N.; Nenes, A. Phytoplankton and cloudiness in the Southern Ocean. Science, 2006, 314, 1419-1423.
6. Kiendler-Scharr, A.; Wildt, J.; Dal Maso, M.; Hohaus, T.; Kleist, E.; Mentel, T. F.; Tillmann, R.; Uerlings, R.; Schurr, U.; Wahner, A. New particle formation in forests inhibited by isoprene emissions. Nature, 2009, 461, 381-384.
7. Wiemer, A. J.; Hohl, R. J.; Wiemer, D. F. The intermediate enzymes of isoprenoid metabolism as anticancer targets. Anticancer Agents Med. Chem., 2009, 9, 526-542.
8. Goldstein, J. L.; Brown, M. S. Regulation of the mevalonate pathway. Nature, 1990, 343, 425-430.
9. Ferguson, J. J.; Durr, I. F.; Rudney, H. The biosynthesis of mevalonic acid. Proc. Natl. Acad. Sci. USA, 1959, 45, 499-504.
10. Tchen, T. T. Mevalonic kinase: purification and properties. J. Biol. Chem., 1958, 233, 1100-1103.
11. Olivier, L. M.; Chambliss, K. L.; Gibson, K. M.; Krisans, S. K. Characterization of phosphomevalonate kinase: chromosomal localization, regulation, and subcellular targeting. J. Lipid Res., 1999, 40, 672-679.
12. Chambliss, K. L.; Slaughter, C. A.; Schreiner, R.; Hoffmann, G. F.; Gibson, K. M. Molecular cloning of human phosphomevalonate kinase and identification of a consensus peroxisomal targeting sequence. J. Biol. Chem., 1996, 271, 17330-17334.
13. Jabalquinto, A. M.; Alvear, M.; Cardemil, E. Physiological aspects and mechanism of action of mevalonate 5-diphosphate decarboxylase. Comp. Biochem. Physiol. B, 1988, 90, 671-677.
14. Rohmer, M.; Knani, M.; Simonin, P.; Sutter, B.; Sahm, H. Isoprenoid biosynthesis in bacteria: a novel pathway for the early steps leading to isopentenyl diphosphate. Biochem. J., 1993, 295 (Pt 2), 517-524.
15. Putra, S. R.; Disch, A.; Bravo, J. M.; Rohmer, M. Distribution of mevalonate and glyceraldehyde 3-phosphate/pyruvate routes for isoprenoid biosynthesis in some gram-negative bacteria and mycobacteria. FEMS Microbiol. Lett., 1998, 164, 169-175.
16. Hunter, W. N. The non-mevalonate pathway of isoprenoid precursor biosynthesis. J. Biol. Chem., 2007, 282, 21573-21577.
17. Jomaa, H.; Wiesner, J.; Sanderbrand, S.; Altincicek, B.; Weidemeyer, C.; Hintz, M.; Turbachova, I.; Eberl, M.; Zeidler, J.; Lichtenthaler, H. K.; Soldati, D.; Beck, E. Inhibitors of the nonmevalonate pathway of isoprenoid biosynthesis as antimalarial drugs. Science, 1999, 285, 1573-1576.
18. Deng, L.; Sundriyal, S.; Rubio, V.; Shi, Z.-z.; Song, Y. Coordination chemistry based approach to lipophilic inhibitors of 1-Deoxyd- xylulose-5-phosphate Reductoisomerase. J. Med. Chem., 2009, 52, 6539-6542.
19. Dhiman, R. K.; Schaeffer, M. L.; Bailey, A. M.; Testa, C. A.; Scherman, H.; Crick, D. C. 1-Deoxy-D-xylulose 5-phosphate reductoisomerase (IspC) from Mycobacterium tuberculosis: towards understanding mycobacterial resistance to fosmidomycin. J. Bacteriol., 2005, 187, 8395-8402.
20. Sakamoto, Y.; Furukawa, S.; Ogihara, H.; Yamasaki, M. Fosmidomycin resistance in adenylate cyclase deficient (cya) mutants of Escherichia coli. Biosci. Biotechnol. Biochem., 2003, 67, 2030-2033.
21. Testa, C. A.; Lherbet, C.; Pojer, F.; Noel, J. P.; Poulter, C. D. Cloning and expression of IspDF from Mesorhizobium loti. Characterization of a bifunctional protein that catalyzes non-consecutive steps in the methylerythritol phosphate pathway. Biochim Biophys Acta - Proteins Proteomics, 2006, 1764, 85-96.
22. Cornish, R. M.; Roth, J. R.; Poulter, C. D. Lethal mutations in the isoprenoid pathway of Salmonella enterica. J. Bacteriol., 2006, 188, 1444-1450.
23. Witting, L. A. and Porter, J. W. Intermediates in the conversion of mevalonic acid to squalene by a rat liver enzyme system. J. Biol. Chem., 1959, 234, 2841-2846.
24. Kabelitz, D. Small molecules for the activation of human gammadelta T cell responses against infection. Recent Pat. Antiinfect. Drug Discov., 2008, 3, 1-9.
25. Leon, A.; Liu, L.; Yang, Y.; Hudock, M. P.; Hall, P.; Yin, F.; Studer, D.; Puan, K.-J.; Morita, C. T.; Oldfield, E. Isoprenoid biosynthesis as a drug target: bisphosphonate inhibition of Escherichia coli K12 growth and synergistic effects of Fosmidomycin. J. Med. Chem., 2006, 49, 7331-7341.
26. Lu, Y. P.; Liu, H. G.; Liang, P. H. Different reaction mechanisms for cis- and trans-prenyltransferases. Biochem. Biophys. Res. Comm., 2009, 379, 351-355.
27. Kajiwara, S.; Fraser, P. D.; Kondo, K.; Misawa, N. Expression of an exogenous isopentenyl diphosphate isomerase gene enhances isoprenoid biosynthesis in Escherichia coli. Biochem. J, 1997, 324 (Pt 2), 421-426.
28. Wieland, B.; Feil, C.; Gloria-Maercker, E.; Thumm, G.; Lechner, M.; Bravo, J. M.; Poralla, K.; Gotz, F. Genetic and biochemical analyses of the biosynthesis of the yellow carotenoid 4,4'- diaponeurosporene of Staphylococcus aureus. J. Bacteriol., 1994, 176, 7719-7726.
29. Song, L. S. A soluble form of phosphatase in Saccharomyces cerevisiae capable of converting farnesyl diphosphate into E, E-farnesol. Appl. Biochem. Biotechnol., 2006, 128, 149-157.
30. Xie, H.; Shao, Y.; Becker, J. M.; Naider, F.; Gibbs, R. A. Synthesis and biological evaluation of the geometric farnesylated analogues of the a-factor mating peptide of Saccharomyces cerevisiae. J. Org. Chem., 2000, 65, 8552-8563.
31. Yu, J. S.; Kleckley, T. S.; Wiemer, D. F. Synthesis of farnesol isomers via a modified Wittig procedure. Org. Lett., 2005, 7, 4803-4806.
32. Mechelke, M. F. and Wiemer, D. F. Synthesis of farnesol Analogues through Cu(I)-mediated displacements of allylic THP ethers by grignard reagents. J. Org. Chem., 1999, 64, 4821-4829.
33. Crane, F. L.; Hatefi, Y.; Lester, R. L.; Widmer, C. Isolation of a quinone from beef heart mitochondria. Biochim. Biophys. Acta, 1957, 25, 220-221.
34. Whistance, G. R.; Dillon, J. F.; Threlfall, D. R. The nature, intergeneric distribution and biosynthesis of isoprenoid quinones and phenols in gram-negative bacteria. Biochem. J., 1969, 111, 461-472.
35. Meganathan, R. Ubiquinone biosynthesis in microorganisms. FEMS Microbiol. Lett., 2001, 203, 131-139.
36. Kawamukai, M. Biosynthesis and bioproduction of coenzyme Q10 by yeasts and other organisms. Biotechnol. Appl. Biochem., 2009, 53, 217-226.
37. Soballe, B. and Poole, R. K. Microbial ubiquinones: multiple roles in respiration, gene regulation and oxidative stress management. Microbiology, 1999, 145 (Pt 8), 1817-1830.
38. Melzer, M. and Heide, L. Characterization of polyprenyldiphosphate: 4-hydroxybenzoate polyprenyltransferase from Escherichia coli. Biochim. Biophys. Acta, 1994, 1212, 93-102.
39. Okada, K.; Minehira, M.; Zhu, X.; Suzuki, K.; Nakagawa, T.; Matsuda, H.; Kawamukai, M. The ispB gene encoding octaprenyl diphosphate synthase is essential for growth of Escherichia coli. J. Bacteriol., 1997, 179, 3058-3060.
40. Kainou, T.; Okada, K.; Suzuki, K.; Nakagawa, T.; Matsuda, H.; Kawamukai, M. Dimer formation of octaprenyl-diphosphate synthase (IspB) is essential for chain length determination of ubiquinone. J. Biol. Chem., 2001, 276, 7876-7883.
41. Gibson, F. and Cox, G. B. The use of mutants of Escherichia coli K12 in studying electron transport and oxidative phosphorylation. Essays Biochem., 1973, 9, 1-29.
42. Daniels, D. L.; Plunkett, G., 3rd; Burland, V.; Blattner, F. R. Analysis of the Escherichia coli genome: DNA sequence of the region from 84.5 to 86.5 minutes. Science, 1992, 257, 771-778.
43. Young, I. G.; Stroobant, P.; Macdonald, C. G.; Gibson, F. Pathway for ubiquinone biosynthesis in Escherichia coli K-12: gene-enzyme relationships and intermediates. J. Bacteriol., 1973, 114, 42-52.
44. Dairi, T. An alternative menaquinone biosynthetic pathway operating in microorganisms: an attractive target for drug discovery to pathogenic Helicobacter and Chlamydia strains. J. Antibiot., (Tokyo) 2009, 62, 347-352.
45. Meganathan, R. Biosynthesis of menaquinone (vitamin K2) and ubiquinone (coenzyme Q): a perspective on enzymatic mechanisms. Vitam. Horm., 2001, 61, 173-218.
46. Dawson, A.; Fyfe, P. K.; Hunter, W. N. Specificity and reactivity in menaquinone biosynthesis: the structure of Escherichia coli MenD (2-succinyl-5-enolpyruvyl-6-hydroxy-3-cyclohexadiene-1- carboxylate synthase). J. Mol. Biol., 2008, 384, 1353-1368.
47. Shaw, D. J.; Guest, J. R.; Meganathan, R.; Bentley, R. Characterization of Escherichia coli men mutants defective in conversion of o-succinylbenzoate to 1,4-dihydroxy-2-naphthoate. J. Bacteriol., 1982, 152, 1132-1137.
48. Suvarna, K.; Stevenson, D.; Meganathan, R.; Hudspeth, M. E. S. Menaquinone (Vitamin K2) biosynthesis: Localization and characterization of the menA gene from Escherichia coli. J. Bacteriol., 1998, 180, 2782-2787.
49. Koike-Takeshita, A.; Koyama, T.; Ogura, K. Identification of a novel gene cluster participating in menaquinone (vitamin K2) biosynthesis. Cloning and sequence determination of the 2- heptaprenyl-1,4-naphthoquinone methyltransferase gene of Bacillus stearothermophilus. J. Biol. Chem., 1997, 272, 12380-12383.
50. Bachmann, B. J. Linkage map of Escherichia coli K-12, edition 8. Microbiol. Rev., 1990, 54, 130-197.
51. Bachmann, B. J. and Low, K. B. Linkage map of Escherichia coli K-12, edition 6. Microbiol. Rev., 1980, 44, 1-56.
52. Berlyn, M. K. B. Linkage map of Escherichia coli K-12, edition 10: the traditional map. Microbiol. Mol. Biol. Rev. 1998, 62, 814-984.
53. Guest, J. R. Anaerobic growth of Escherichia coli K12 with fumarate as terminal electron acceptor. Genetic studies with menaquinone and fluoroacetate-resistant mutants. J. Gen. Microbiol. 1979, 115, 259-271.
54. Lee, P. T.; Hsu, A. Y.; Ha, H. T.; Clarke, C. F. A Cmethyltransferase involved in both ubiquinone and menaquinone biosynthesis: isolation and identification of the Escherichia coli ubiE gene. J. Bacteriol., 1997, 179, 1748-1754.
55. Hiratsuka, T.; Furihata, K.; Ishikawa, J.; Yamashita, H.; Itoh, N.; Seto, H.; Dairi, T. An alternative menaquinone biosynthetic pathway operating in microorganisms. Science, 2008, 321, 1670-1673.
56. Hiratsuka, T.; Itoh, N.; Seto, H.; Dairi, T. Enzymatic properties of futalosine hydrolase, an enzyme essential to a newly identified menaquinone biosynthetic pathway. Biosci. Biotechnol. Biochem., 2009, 73, 1137-1141.
57. Okano, T.; Nakagawa, K.; Kamao, M. Vitamin K and Bone Update. In vivo Metabolism of Vitamin K. - In relation to the conversion of vitamin K(1) to MK-4. Clin. Calcium, 2009, 19, 1779-1787.
58. Philips, M. R. and Cox, A. D. Geranylgeranyltransferase I as a target for anti-cancer drugs. J. Clin. Invest, 2007, 117, 1223-1225.
59. Zhu, K.; Hamilton, A. D.; Sebti, S. M. Farnesyltransferase inhibitors as anticancer agents: current status. Curr. Opin. Investig. Drugs, 2003, 4, 1428-1435.
60. Swanson, K. M. and Hohl, R. J. Anti-cancer therapy: targeting the mevalonate pathway. Curr. Cancer Drug Targets, 2006, 6, 15-37.
61. Lopez, L. C.; Schuelke, M.; Quinzii, C. M.; Kanki, T.; Rodenburg, R. J.; Naini, A.; Dimauro, S.; Hirano, M. Leigh syndrome with nephropathy and CoQ10 deficiency due to decaprenyl diphosphate synthase subunit 2 (PDSS2) mutations. Am. J. Hum. Genet., 2006, 79, 1125-1129.
62. Saiki, R.; Lunceford, A. L.; Shi, Y.; Marbois, B.; King, R.; Pachuski, J.; Kawamukai, M.; Gasser, D. L.; Clarke, C. F. Coenzyme Q10 supplementation rescues renal disease in Pdss2kd/kd mice with mutations in prenyl diphosphate synthase subunit 2. Am. J. Physiol. Renal Physiol., 2008, 295, F1535-1544.
63. Guo, R. T.; Kuo, C. J.; Chou, C. C.; Ko, T. P.; Shr, H. L.; Liang, P. H.; Wang, A. H. Crystal structure of octaprenyl pyrophosphate synthase from hyperthermophilic Thermotoga maritima and mechanism of product chain length determination. J. Biol. Chem., 2004, 279, 4903-4912.
64. Choi, J. H.; Ryu, Y. W.; Park, Y. C.; Seo, J. H. Synergistic effects of chromosomal ispB deletion and dxs overexpression on coenzyme Q(10) production in recombinant Escherichia coli expressing Agrobacterium tumefaciens dps gene. J. Biotechnol., 2009, 144, 64-69.
65. Liu, X.; Yuan, Q.; Zhang, H. Residues around the catalytic pocket of DdsA are important for isoprenoids chain elongation. Protein Pept. Lett., 2007, 14, 27-32.
66. Guo, R. T.; Cao, R.; Liang, P. H.; Ko, T. P.; Chang, T. H.; Hudock, M. P.; Jeng, W. Y.; Chen, C. K.; Zhang, Y.; Song, Y.; Kuo, C. J.; Yin, F.; Oldfield, E.; Wang, A. H. Bisphosphonates target multiple sites in both cis- and trans-prenyltransferases. Proc. Natl. Acad. Sci. USA, 2007, 104, 10022-10027.
67. Tonhosolo, R.; D'Alexandri, F. L.; Genta, F. A.; Wunderlich, G.; Gozzo, F. C.; Eberlin, M. N.; Peres, V. J.; Kimura, E. A.; Katzin, A. M. Identification, molecular cloning and functional characterization of an octaprenyl pyrophosphate synthase in intra-erythrocytic stages of Plasmodium falciparum. Biochem. J., 2005, 392, 117-126.
68. Gerdes, S. Y.; Scholle, M. D.; Campbell, J. W.; Balazsi, G.; Ravasz, E.; Daugherty, M. D.; Somera, A. L.; Kyrpides, N. C.; Anderson, I.; Gelfand, M. S.; Bhattacharya, A.; Kapatral, V.; D'Souza, M.; Baev, M. V.; Grechkin, Y.; Mseeh, F.; Fonstein, M. Y.; Overbeek, R.; Barabasi, A. L.; Oltvai, Z. N.; Osterman, A. L. Experimental determination and system level analysis of essential genes in Escherichia coli MG1655. J. Bacteriol., 2003, 185, 5673-5684.
69. Zakharova, S.; Fulhorst, M.; Luczak, L.; Wessjohann, L. Synthesis, inhibitory and activation properties of prenyldiphosphate mimics for aromatic prenylations with ubiA-prenyltransferase. Arkivoc, 2004, 79-96.
70. Hohl, R. J.; Lewis, K. A.; Cermak, D. M.; Wiemer, D. F. Stereochemistry- dependent inhibition of RAS farnesylation by farnesyl phosphonic acids. Lipids, 1998, 33, 39-46.
71. Gibbs, J. B.; Pompliano, D. L.; Mosser, S. D.; Rands, E.; Lingham, R. B.; Singh, S. B.; Scolnick, E. M.; Kohl, N. E.; Oliff, A. Selective inhibition of farnesyl-protein transferase blocks ras processing in vivo. J. Biol. Chem., 1993, 268, 7617-7620.
72. Pompliano, D. L.; Rands, E.; Schaber, M. D.; Mosser, S. D.; Anthony, N. J.; Gibbs, J. B. Steady-state kinetic mechanism of Ras farnesyl:protein transferase. Biochemistry, 1992, 31, 3800-3807.
73. Kurosu, M.; Crick, D. C. MenA is a promising drug target for developing novel lead molecules to combat Mycobacterium tuberculosis. Med. Chem., 2009, 5, 197-207.
74. Dhiman, R. K.; Mahapatra, S.; Slayden, R. A.; Boyne, M. E.; Lenaerts, A.; Hinshaw, J. C.; Angala, S. K.; Chatterjee, D.; Biswas, K.; Narayanasamy, P.; Kurosu, M.; Crick, D. C. Menaquinone synthesis is critical for maintaining mycobacterial viability during exponential growth and recovery from non-replicating persistence. Mol. Microbiol., 2009, 72, 85-97.
75. Kurosu, M.; Narayanasamy, P.; Biswas, K.; Dhiman, R.; Crick, D. C. Discovery of 1,4-dihydroxy-2-naphthoate prenyltransferase inhibitors: new drug leads for multidrug-resistant gram-positive pathogens. J. Med. Chem., 2007, 50, 3973-3975.
76. Schleifer, K. H. and Kandler, O. Peptidoglycan types of bacterial cell walls and their taxonomic implications. Bacteriol. Rev., 1972, 36, 407-477.
77. Vollmer, W.; Blanot, D.; de Pedro, M. A. Peptidoglycan structure and architecture. FEMS Microbiol. Rev., 2008, 32, 149-167.
78. de Kruijff, B.; van Dam, V.; Breukink, E. Lipid II: A central component in bacterial cell wall synthesis and a target for antibiotics. Prostaglandins Leukot. Essent. Fatty Acids, 2008, 79, 117-121.
79. van Heijenoort, J. Lipid intermediates in the biosynthesis of bacterial peptidoglycan. Microbiol. Mol. Biol. Rev., 2007, 71, 620-635.
80. Payne, D. J.; Gwynn, M. N.; Holmes, D. J.; Pompliano, D. L. Drugs for bad bugs: confronting the challenges of antibacterial discovery. Nat. Rev. Drug Discov., 2007, 6, 29-40.
81. Bouhss, A.; Trunkfield, A. E.; Bugg, T. D.; Mengin-Lecreulx, D. The biosynthesis of peptidoglycan lipid-linked intermediates. FEMS Microbiol. Rev., 2008, 32, 208-233.
82. Chojnacki, T. and Dallner, G. The biological role of dolichol. Biochem. J., 1988, 251, 1-9.
83. Liang, P. H.; Ko, T. P.; Wang, A. H. Structure, mechanism and function of prenyltransferases. Eur. J. Biochem., 2002, 269, 3339-3354.
84. Poulter, C. D.; Rilling, H. C. Prenyltransferase: the mechanism of the reaction. Biochemistry, 1976, 15, 1079-1083.
85. Guo, R. T.; Ko, T. P.; Chen, A. P.; Kuo, C. J.; Wang, A. H.; Liang, P. H. Crystal structures of undecaprenyl pyrophosphate synthase in complex with magnesium, isopentenyl pyrophosphate, and farnesyl thiopyrophosphate: roles of the metal ion and conserved residues in catalysis. J. Biol. Chem., 2005, 280, 20762-20774.
86. El Ghachi, M.; Bouhss, A.; Blanot, D.; Mengin-Lecreulx, D. The bacA gene of Escherichia coli encodes an undecaprenyl pyrophosphate phosphatase activity. J. Biol. Chem., 2004, 279, 30106-30113.
87. El Ghachi, M.; Derbise, A.; Bouhss, A.; Mengin-Lecreulx, D. Identification of multiple genes encoding membrane proteins with undecaprenyl pyrophosphate phosphatase (UppP) activity in Escherichia coli. J. Biol. Chem., 2005, 280, 18689-18695.
88. Apfel, C. M.; Takacs, B.; Fountoulakis, M.; Stieger, M.; Keck, W. Use of genomics to identify bacterial undecaprenyl pyrophosphate synthetase: cloning, expression, and characterization of the essential uppS gene. J. Bacteriol., 1999, 181, 483-492.
89. Touze, T.; Tran, A. X.; Hankins, J. V.; Mengin-Lecreulx, D.; Trent, M. S. Periplasmic phosphorylation of lipid A is linked to the synthesis of undecaprenyl phosphate. Mol. Microbiol., 2008, 67, 264-277.
90. Kato, J.; Fujisaki, S.; Nakajima, K.; Nishimura, Y.; Sato, M.; Nakano, A. The Escherichia coli homologue of yeast RER2, a key enzyme of dolichol synthesis, is essential for carrier lipid formation in bacterial cell wall synthesis. J. Bacteriol., 1999, 181, 2733-2738.
91. Tatar, L. D.; Marolda, C. L.; Polischuk, A. N.; van Leeuwen, D.; Valvano, M. A. An Escherichia coli undecaprenyl-pyrophosphatephosphatase implicated in undecaprenyl phosphate recycling. Microbiology, 2007, 153, 2518-2529.
92. Mengin-Lecreulx, D.; Ayala, J.; Bouhss, A.; van Heijenoort, J.; Parquet, C.; Hara, H. Contribution of the Pmra promoter to expression of genes in the Escherichia coli mra cluster of cell envelope biosynthesis and cell division genes. J. Bacteriol., 1998, 180, 4406-4412.
93. Hara, H.; Yasuda, S.; Horiuchi, K.; Park, J. T. A promoter for the first nine genes of the Escherichia coli mra cluster of cell division and cell envelope biosynthesis genes, including ftsI and ftsW. J. Bacteriol., 1997, 179, 5802-5811.
94. Mengin-Lecreulx, D.; Texier, L.; Rousseau, M.; van Heijenoort, J. The murG gene of Escherichia coli codes for the UDP-Nacetylglucosamine: N-acetylmuramyl-(pentapeptide) pyrophosphoryl-undecaprenol N-acetylglucosamine transferase involved in the membrane steps of peptidoglycan synthesis. J. Bacteriol., 1991, 173, 4625-4636.
95. Boyle, D. S.; Donachie, W. D. mraY is an essential gene for cell growth in Escherichia coli. J. Bacteriol., 1998, 180, 6429-6432.
96. Lara, B.; Mengin-Lecreulx, D.; Ayala, J. A.; van Heijenoort, J. Peptidoglycan precursor pools associated with MraY and FtsW deficiencies or antibiotic treatments. FEMS Microbiol. Lett., 2005, 250, 195-200.
97. Zawadzke, L. E.; Wu, P.; Cook, L.; Fan, L.; Casperson, M.; Kishnani, M.; Calambur, D.; Hofstead, S. J.; Padmanabha, R. Targeting the MraY and MurG bacterial enzymes for antimicrobial therapeutic intervention. Anal. Biochem., 2003, 314, 243-252.
98. Storm, D. R. and Strominger, J. L. Complex-Formation between Bacitracin Peptides and Isoprenyl Pyrophosphates - Specificity of Lipid-Peptide Interactions. J. Biol. Chem., 1973, 248, 3940-3945.
99. Siewert, G.; Strominger, J. L. Bacitracin: An inhibitor of the dephosphorylation of lipid pyrophosphate, an intermediate in the biosynthesis of the peptidoglycan of bacterial cell walls. Proc. Natl. Acad. Sci. USA, 1967, 57, 767-773.
100. Banerjee, D. K. Amphomycin inhibits mannosylphosphoryldolichol synthesis by forming a complex with dolichylmonophosphate. J. Biol. Chem., 1989, 264, 2024-2028.
101. Chen, A. P.; Chang, S. Y.; Lin, Y. C.; Sun, Y. S.; Chen, C. T.; Wang, A. H.; Liang, P. H. Substrate and product specificities of cis-type undecaprenyl pyrophosphate synthase. Biochem. J., 2005, 386, 169-176.
102. Marecak, D. M.; Horiuchi, Y.; Arai, H.; Shimonaga, M.; Maki, Y.; Koyama, T.; Ogura, K.; Prestwich, G. D. Benzoylphenoxy analogs of isoprenoid diphosphates as photoactivatable substrates for bacterial prenyltransferases. Bioorg. Med. Chem. Lett., 1997, 7, 1973-1978.
103. Chen, A. P.; Chen, Y. H.; Liu, H. P.; Li, Y. C.; Chen, C. T.; Liang, P. H. Synthesis and application of a fluorescent substrate analogueto study ligand interactions for undecaprenyl pyrophosphate synthase. J. Am. Chem. Soc.,2002, 124, 15217-15224.
104. Scholte, A. A.; Eubanks, L. M.; Poulter, C. D.; Vederas, J. C. Synthesis and biological activity of isopentenyl diphosphate analogues. Bioorg. Med. Chem., 2004, 12, 763-770.
105. Peukert, S.; Sun, Y.; Zhang, R.; Hurley, B.; Sabio, M.; Shen, X.; Gray, C.; Dzink-Fox, J.; Tao, J.; Cebula, R.; Wattanasin, S. Design and structure-activity relationships of potent and selective inhibitors of undecaprenyl pyrophosphate synthase (UPPS): tetramic, tetronic acids and dihydropyridin-2-ones. Bioorg. Med. Chem. Lett., 2008, 18, 1840-1844.
106. Liu, C. I.; Liu, G. Y.; Song, Y.; Yin, F.; Hensler, M. E.; Jeng, W. Y.; Nizet, V.; Wang, A. H.; Oldfield, E. A cholesterol biosynthesis inhibitor blocks Staphylococcus aureus virulence. Science, 2008, 319, 1391-1394.
107. Wiemer, A. J.; Yu, J. S.; Shull, L. W.; Barney, R. J.; Wasko, B. M.; Lamb, K. M.; Hohl, R. J.; Wiemer, D. F. Pivaloyloxymethylmodified isoprenoid bisphosphonates display enhanced inhibition of cellular geranylgeranylation. Bioorg. Med. Chem., 2008, 16, 3652-3660.
108. Wiemer, A. J.; Yu, J. S.; Lamb, K. M.; Hohl, R. J.; Wiemer, D. F. Mono- and dialkyl isoprenoid bisphosphonates as geranylgeranyl diphosphate synthase inhibitors. Bioorg. Med. Chem., 2008, 16, 390-399.
109. Maalouf, M. A.; Wiemer, A. J.; Kuder, C. H.; Hohl, R. J.; Wiemer, D. F. Synthesis of fluorescently tagged isoprenoid bisphosphonates that inhibit protein geranylgeranylation. Bioorg. Med. Chem., 2007, 15, 1959-1966.
110. Wiemer, A. J.; Tong, H.; Swanson, K. M.; Hohl, R. J. Digeranyl bisphosphonate inhibits geranylgeranyl pyrophosphate synthase. Biochem. Biophys. Res. Commun., 2007, 353, 921-925.
111. Shull, L. W.; Wiemer, A. J.; Hohl, R. J.; Wiemer, D. F. Synthesis and biological activity of isoprenoid bisphosphonates. Bioorg. Med. Chem., 2006, 14, 4130-4136.
112. Szabo, C. M.; Matsumura, Y.; Fukura, S.; Martin, M. B.; Sanders, J. M.; Sengupta, S.; Cieslak, J. A.; Loftus, T. C.; Lea, C. R.; Lee, H. J.; Koohang, A.; Coates, R. M.; Sagami, H.; Oldfield, E. Inhibition of geranylgeranyl diphosphate synthase by bisphosphonates and diphosphates: a potential route to new bone antiresorption and antiparasitic agents. J. Med. Chem., 2002, 45, 2185-2196.
113. Sanders, J. M.; Ghosh, S.; Chan, J. M. W.; Meints, G.; Wang, H.; Raker, A. M.; Song, Y.; Colantino, A.; Burzynska, A.; Kafarski, P.; Morita, C. T.; Oldfield, E. Quantitative structure-activity relation ships for gammadelta T cell activation by bisphosphonates. J. Med. Chem., 2004, 47, 375-384.
114. Grajkowski, A.; Pedras-Vasconcelos, J.; Wang, V.; Ausin, C.; Hess, S.; Verthelyi, D.; Beaucage, S. L. Thermolytic CpGcontaining DNA oligonucleotides as potential immunotherapeutic prodrugs. Nucleic Acids Res., 2005, 33, 3550-3560.
115. Kudoh, T.; Park, C. S.; Lefurgy, S. T.; Sun, M.; Michels, T.; Leyh, T. S.; Silverman, R. B. Mevalonate analogues as substrates of enzymes in the isoprenoid biosynthetic pathway of Streptococcus pneumoniae. Bioorg. Med. Chem., 2009, 18(3),1124-1134
116. Fujisaki, S.; Nishino, T.; Katsuki, H.; Hara, H.; Nishimura, Y.; Hirota, Y. Isolation and characterization of an Escherichia coli mutant having temperature-sensitive farnesyl diphosphate synthase. J. Bacteriol., 1989, 171, 5654-5658.
117. Fujisaki, S.; Takahashi, I.; Hara, H.; Horiuchi, K.; Nishino, T.; Nishimura, Y. Disruption of the structural gene for farnesyl diphosphate synthase in Escherichia coli. J. Biochem., 2005, 137, 395-400.